R D Kennedy
Overview
Explore the profile of R D Kennedy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scanlon E, Lavery A, Albraikat M, Stevenson L, Kennedy C, Byrne R, et al.
ESMO Open
. 2024 Oct;
9(11):103930.
PMID: 39395265
Background: The Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC) trial reported an acceptable safety profile for neoadjuvant oxaliplatin and capecitabine (Xelox) ± AZD8931 in oesophageal adenocarcinoma (OAC) but limited...
2.
Baxter M, Spender L, Cairns D, Walsh S, Oparka R, Porter R, et al.
ESMO Open
. 2024 May;
9(5):103450.
PMID: 38744099
Background: An improved understanding of which gastroesophageal adenocarcinoma (GOA) patients respond to both chemotherapy and immune checkpoint inhibitors (ICI) is needed. We investigated the predictive role and underlying biology of...
3.
Hardesty J, Kaplan B, Martini S, Megatsari H, Kennedy R, Cohen J
Public Health
. 2019 Jun;
172:40-42.
PMID: 31158567
Objectives: Nationally representative studies suggest 1-2% of Indonesian women (2.3 million) smoke various tobacco products daily; however, in recent years, there has been concern that the tobacco industry has successfully...
4.
Jain S, Lyons C, Walker S, McQuaid S, Hynes S, Mitchell D, et al.
Ann Oncol
. 2017 Oct;
29(1):215-222.
PMID: 29045551
Background: Radiotherapy is an effective treatment of intermediate/high-risk locally advanced prostate cancer, however, >30% of patients relapse within 5 years. Clinicopathological parameters currently fail to identify patients prone to systemic...
5.
Abuelaish I, Seidenberg A, Kennedy R, Rees V
East Mediterr Health J
. 2014 Mar;
19(5):447-51.
PMID: 24617123
Second-hand smoke is a major cause of preventable disease and death in the Eastern Mediterranean Region. To assess how second-hand smoke impacts air quality, respirable suspended particles (PM2.5) which are...
6.
Tkocz D, Crawford N, Buckley N, Berry F, Kennedy R, Gorski J, et al.
Oncogene
. 2011 Nov;
31(32):3667-78.
PMID: 22120723
In this study we describe a novel interaction between the breast/ovarian tumor suppressor gene BRCA1 and the transcription factor GATA3, an interaction, which is important for normal breast differentiation. We...
7.
Affolder T, Akimoto H, Akopian A, Albrow M, Amaral P, Amendolia S, et al.
Phys Rev Lett
. 2011 Sep;
84(8):1663-8.
PMID: 21923205
We have studied the production of B hadrons in 1.8-TeV pp[over ¯] collisions. We present measurements of the fragmentation fractions, f_{u}, f_{d}, f_{s}, and f_{baryon}, of produced b quarks that...
8.
Redmond K, Crawford N, Farmer H, DCosta Z, OBrien G, Buckley N, et al.
Oncogene
. 2010 Mar;
29(22):3252-62.
PMID: 20348948
T-box 2 (TBX2) is a transcription factor involved in mammary development and is known to be overexpressed in a subset of aggressive breast cancers. TBX2 has previously been shown to...
9.
Acosta D, Affolder T, Albrow M, Ambrose D, Amidei D, Anikeev K, et al.
Phys Rev Lett
. 2005 Aug;
95(5):051801.
PMID: 16090863
We present a new search for H0V production, where H0 is a scalar Higgs boson decaying into bb with branching ratio beta, and V is a Z0 boson decaying into...
10.
Acosta D, Affolder T, Albrow M, Ambrose D, Amidei D, Anikeev K, et al.
Phys Rev Lett
. 2005 May;
94(17):171802.
PMID: 15904280
We report the first largely model independent measurement of charged particle multiplicities in quark and gluon jets, Nq and Ng, produced at the Fermilab Tevatron in pp collisions with a...